InvestSMART

Factor Therapeutics Limited (ASX: FTT) - Announcements

- Current share price for FTT : $0.005

ASX company news and announcements for Factor Therapeutics Limited (FTT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Factor Therapeutics Limited (FTT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Factor Therapeutics Limited (FTT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Factor Therapeutics Limited (FTT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change in substantial holding 30 May 2017 4:58PM $0.062 $0.005 fallen by 91.94%
- Dr. Christian Behrenbruch transitions to NED 22 May 2017 8:41AM $0.061 $0.005 fallen by 91.80%
- Appointment of Dr. Rosalind Wilson as CEO 22 May 2017 8:38AM $0.061 $0.005 fallen by 91.80%
- Becoming a substantial holder 15 May 2017 7:08PM $0.057 $0.005 fallen by 91.23%
- Appendix 4C 27 Apr 2017 8:27AM $0.062 $0.005 fallen by 91.94%
- Phase II clinical trial progress update 7 Apr 2017 8:35AM $0.068 $0.005 fallen by 92.65%
- Shareholder Update - Q1 2017 3 Apr 2017 8:19AM $0.070 $0.005 fallen by 92.86%
- Half Year Accounts 15 Feb 2017 9:30AM $0.060 $0.005 fallen by 91.67%
- Initial Director's Interest Notice - John Michailidis 14 Feb 2017 1:21PM $0.062 $0.005 fallen by 91.94%
- Appointment of John Michailidis as Non-Executive Director 14 Feb 2017 1:19PM $0.062 $0.005 fallen by 91.94%
- Unmarketable parcel sale facility 13 Feb 2017 12:10AM $0.062 $0.005 fallen by 91.94%
- Appendix 4C - December 2016 quarter 24 Jan 2017 8:27AM $0.065 $0.005 fallen by 92.31%
- Biotech Showcase Presentation 11 Jan 2017 8:42AM $0.058 $0.005 fallen by 91.38%
- Phase II Clinical Trial - First Patient In 20 Dec 2016 11:28AM $0.064 $0.005 fallen by 92.19%
- Appendix 3Y - Mr Tim Hughes (correction) 23 Nov 2016 5:56PM $0.081 $0.005 fallen by 93.83%
- Appendix 3Y - Dr Chris Behrenbruch (correction) 23 Nov 2016 5:55PM $0.081 $0.005 fallen by 93.83%
- Appendix 3Y - Dr Cherrell Hirst (correction) 23 Nov 2016 5:53PM $0.081 $0.005 fallen by 93.83%
- Appendix 3Y - Dr Robert Ryan (options) 23 Nov 2016 5:47PM $0.081 $0.005 fallen by 93.83%
- Appendix 3B - unlisted share options following AGM 23 Nov 2016 5:46PM $0.081 $0.005 fallen by 93.83%
- Constitution of Factor Therapeutics Limited 23 Nov 2016 1:11PM $0.080 $0.005 fallen by 93.75%
- AGM Results of Meeting 23 Nov 2016 1:07PM $0.080 $0.005 fallen by 93.75%
- Executive Team presentation to AGM 23 Nov 2016 10:11AM $0.078 $0.005 fallen by 93.59%
- Chairman's Address to AGM 23 Nov 2016 10:10AM $0.078 $0.005 fallen by 93.59%
- Collaboration and IP option agreement with Monash University 22 Nov 2016 2:15PM $0.080 $0.005 fallen by 93.75%
- Investor Update 22 Nov 2016 8:29AM $0.076 $0.005 fallen by 93.42%

201 - 225 of 260 results

Page 9 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.